Treatment of Leg Pain Due to Varicella Zoster
For leg pain due to varicella zoster (shingles), oral antiviral therapy with acyclovir, valacyclovir, or famciclovir is the first-line treatment and should be initiated as soon as possible to reduce pain duration and severity. 1
Antiviral Therapy Options
- For uncomplicated herpes zoster affecting the leg, oral acyclovir (800 mg 5 times daily for 7-10 days) or valacyclovir (1000 mg 3 times daily for 7 days) is recommended until all lesions have scabbed 2, 1
- Valacyclovir is preferred over acyclovir due to its simpler dosing regimen and superior bioavailability, which has been shown to accelerate the resolution of zoster-associated pain compared to acyclovir 3, 4
- For immunocompromised patients or those with disseminated disease, intravenous acyclovir is recommended with temporary reduction in immunosuppressive medication if applicable 2
Pain Management Approach
- Antiviral therapy alone significantly reduces the duration of acute pain and decreases the risk of postherpetic neuralgia 4
- Valacyclovir has been shown to reduce the duration of zoster-associated pain more effectively than acyclovir (median pain durations of 38 days versus 51 days) 4
- Pain management should be initiated concurrently with antiviral therapy using:
Special Considerations
For immunocompromised patients with herpes zoster:
For patients with renal impairment, acyclovir dosage should be adjusted based on creatinine clearance 5:
- CrCl >25 mL/min: 800 mg every 4 hours, 5 times daily
- CrCl 10-25 mL/min: 800 mg every 8 hours
- CrCl <10 mL/min: 800 mg every 12 hours
Timing of Treatment
- Antiviral therapy should ideally be initiated within 72 hours of rash onset for maximum efficacy 3, 4
- However, treatment may still be beneficial when started later than 72 hours after rash onset, particularly in patients with ongoing new lesion formation or in immunocompromised hosts 6
Treatment Duration
- Standard treatment duration is 7 days for immunocompetent patients 2, 1
- Extending treatment to 14 days has not shown significant advantage over the 7-day regimen in clinical studies 6
- For immunocompromised patients, treatment should continue until all lesions have scabbed 2
Monitoring and Follow-up
- Monitor for resolution of skin lesions and improvement in pain 2
- If pain persists beyond 30 days after rash onset (postherpetic neuralgia), consider referral to pain specialist 1
- For immunocompromised patients, monitor for potential dissemination and consider switching to IV therapy if clinical deterioration occurs 2